A study that involved 33 young patients (<40 years) with cervical neoplasms has found that more than half of tumor cells express nuclear GHR in 61% of those patients and has suggested that a high degree of nuclear GHR may be a promoter of stimulating the progression of cervical carcinoma cells [190]. Here, GHR is linked to cervical carcinoma.